Companies / Turkey
If you would like to subscribe to Middle East & Africa Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Middle East & Africa Pharma & Healthcare Insight please click on the trial link below.
Drug Sector Witnessing Rapid Growth
January 2007 | Industry NewsSorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Middle East & Africa Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Middle East & Africa Pharma & Healthcare Insight please click on the trial link below.
The Turkish drug sector is expected to develop strong in the coming years, as the importance of emerging markets grow, claims the Secretary-General of the Association of Research-based Pharmaceutical Companies. By 2007, global pharmaceutical sales are forecast to reach US$665-685bn, and 30% of growth will be attributable to developing countries.